Form EFFECT TFF Pharmaceuticals,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 7, 2025 |
| Accession Number: | 0001213900-25-021109 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- INTURAI VENTURES SIGNS EXCLUSIVE LOI TO ACQUIRE AI-DRIVEN DRONE SWARM C2 COMMAND PLATFORM
- Citi Appointed as Depositary Bank for Vicore Pharma Holding AB’s ADR Program
- Himax Technologies, Inc. Schedules Second Quarter 2026 Financial Results Conference Call on Thursday, August 6, 2026 at 8:00 AM EDT
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
